Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» oncology
oncology
Acepodia Secures $100 Million Series D Financing to Advance
BioSpace
Tue, 06/6/23 - 10:02 am
Acepodia
funding
oncology
gamma delta T cells
ACE1831
Pricing law jeopardizes post-approval R&D process for cancer pills: analysis
Medical Marketing and Media
Mon, 06/5/23 - 10:04 pm
Inflation Reduction Act
R&D
drug pricing
oncology
Bayer to acquire exclusive license from Cedilla Therapeutics on selective inhibitors in pre-clinical precision oncology
BioSpace
Thu, 06/1/23 - 06:43 pm
Bayer
Cedilla Therapeutics
CyclinE1/CDK2 inhibitors
oncology
precision oncology
Rain Oncology to cut 65% of staff after milademetan Phase 3 trial failure
Medical Marketing and Media
Wed, 05/31/23 - 11:00 am
Rain Oncology
layoffs
clinical trials
milademetan
oncology
solid tumors
Takeda puts $510M on the line to expand KSQ cancer collaboration
Fierce Biotech
Wed, 05/17/23 - 10:09 am
Takeda
KSQ Therapeutics
cancer
oncology
Astellas, Sony Team on Novel ADC Platform for Oncology
BioSpace
Tue, 05/16/23 - 12:20 pm
Astellas
Sony Corporation
antibody-drug conjugate
oncology
Why Shares of Cassava Sciences Jumped Last Week
Motley Fool
Mon, 05/15/23 - 10:10 am
Cassava Sciences
Simulfilam
oncology
cancer
This Startup Just Raised $90M To Fight Cancer
Crunchbase
Thu, 05/4/23 - 09:15 am
Convergent Therapeutics
funding
oncology
radiopharmaceuticals
prostate cancer
White House rolls out new cancer initiative to help implement ‘Moonshot’
The Hill
Wed, 04/5/23 - 10:19 am
cancer
oncology
White House
cancer moonshot
OncoRix's breast cancer integrative solution demonstrated enhanced efficacy when combined with chemotherapy in an ex-vivo model
BioSpace
Fri, 03/31/23 - 10:33 am
OncoRix
breast cancer
oncology
Bicycle, Novartis Ink Oncology Deal Worth up to $1.7B
BioSpace
Tue, 03/28/23 - 11:30 am
Bicycle Therapeutics
Novartis
drug discovery
oncology
radioligand
AbbVie sidelines CytomX after seeing midphase oncology ADC data, opens talks on returning lead drug
Fierce Biotech
Tue, 03/28/23 - 10:22 am
AbbVie
CytomX Therapeutics
cancer
oncology
antibody-drug conjugate
Proposed FDA guidelines to strengthen oversight on accelerated approval cancer drugs
Medical Marketing and Media
Mon, 03/27/23 - 09:57 pm
FDA
clinical trials
cancer
oncology
accelerated approvals
FDA floats oncology authorization shake-up, pitching 'one-trial' model for accelerated and full approval
Fierce Biotech
Mon, 03/27/23 - 10:14 am
FDA
oncology
regulatory
BioNTech signs deal to co-develop OncoC4's cancer drug
Reuters
Tue, 03/21/23 - 10:05 am
BioNTech
OncoC4
cancer
oncology
drug development
ONC-392
BioXcel takes surprising path with IPO of oncology spinout OnkosXcel
Fierce Biotech
Wed, 03/15/23 - 09:37 pm
BioXcel
IPOs
oncology
OnkosXcel
Exscientia builds cancer pipeline with two BMS drugs
Pharmaphorum
Wed, 03/15/23 - 09:57 am
Exscientia
Bristol Myers Squibb
oncology
EXS73565
EXS74539
The state of the oncology microbiome therapeutics pipeline at a glance
Clinical Trials Arena
Fri, 03/10/23 - 11:23 am
oncology
cancer
microbiome
drug development
Lantern Pharma announces plans to enhance oncology drug discovery
Outsourcing Pharma
Tue, 02/21/23 - 10:24 am
Lantern Pharma
drug discovery
oncology
machine learning
artificial intelligence
On the turnaround trail, tiny Corbus pays $7.5M for rival to Seagen's oncology ADC Padcev
Fierce Biotech
Mon, 02/13/23 - 10:29 am
Corbus Pharmaceuticals
Seagen
Padcev
CRB-701
oncology
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
…
next ›
last »